MSF urges public and non-profit actors to publish clinical trial costs to improve access to medical products

With routine vaccination efforts failing to reach people in fragile and emergency settings, MSF is seeing low vaccination coverage and more outbreaks of vaccine-preventable diseases, like diphtheria and measles

MSF study in JAMA estimates the costs of production of new diabetes drugs and insulin pens

Ten years after West Africa Ebola outbreak, MSF calls for global emergency stockpile of Ebola treatments

Leaked text shows India-EFTA trade deal includes excessive intellectual property provisions that may require India to gut pro-public health national laws, which may undermine people's access to affordable medicines from India

MSF welcomes Colombia taking a historic next step towards issuing first-ever compulsory license to increase access to more affordable generic versions of key HIV medicine dolutegravir

With increasing number of vaccine-preventable disease outbreaks, urgently tackling glaring childhood immunisation shortfalls must be priority for Gavi and Board

Recent price reductions to WHO-recommended TB tests and treatment should enable more countries to make these vital medical tools available

Governments must now turn words on paper into practice and take the necessary steps to save more lives of people with TB

MSF again called on Gavi to broaden catch-up vaccine coverage for children by waiving co-financing requirements of countries with fragile health systems

MSF calls on Johnson & Johnson not to enforce its secondary patents on TB drug bedaquiline

Gavi must do more to vaccinate children up to age five, and waive co-financing requirements of countries with fragile health systems or in humanitarian crisis

MSF warned that access to point-of-care CD4 tests for HIV are under threat because Abbott and Becton Dickinson have decided to stop production

Access to TB drug bedaquiline, a backbone medicine for drug-resistant TB treatment regimens, remains out of reach for too many

For World Immunization Week 2023, MSF calls on Gavi to expand its policy to catch up young children on missed vaccinations.

2019 patent challenge by TB survivors, Nandita Venkatesan and Phumeza Tisile, was successful against J&J's secondary patent application for bedaquiline.

MSF called on governments and donors to speed up access to diagnostic tests, and shorter, safer and more effective treatments, for DR-TB.

Findings that prompted WHO to update global DR-TB treatment guidelines now published in the New England Journal of Medicine, show that a much shorter treatment regimen for drug-resistant TB is safer and cured almost 90 percent of ...

MSF calls on ViiV to urgently dismantle barriers to access for long-acting cabotegravir

A MSF report released today finds that two newer TB drugs – bedaquiline and delamanid – going off patent in 2023 presents a critical opportunity to increase access to shorter, safer and better treatment for people with drug-resistant ...